Purple Innovation and Edgewise Therapeutics Stock See Action From Activist Investors | Barron’s

Coliseum Capital acquired almost half of the publicly traded shares of mattress firm Purple. OrbiMed Advisors increased its stake in pharmaceutical firm Edgewise Therapeutics.